Thang Vo-ta ^Leaders

Thang Vo-Ta is currently a Translational Health Sciences Programme Alumni at the University of Oxford, where he is furthering his expertise in clinical trials and biotechnology. As the CEO and Co-Founder of Calla Lily Clinical Care, based in London, he leads the development of Callavid, a patented delivery platform for vaginally-delivered drugs, addressing critical needs in womens health, particularly in miscarriage prevention and IVF. Previously, Thang co-founded Calla Lily Personal Care, where he introduced the award-winning Tampliner, recognized as one of TIME magazines Best Inventions. His extensive career includes roles at Goldman Sachs and Manhattan Loft Corporation, showcasing his diverse experience in investment and real estate. Thang has been acknowledged in several prestigious lists, including the Healthcare Technology Reports Top 25 Consumer HealthTech Executives and The Manufacturers Top 100 Innovators. His commitment to innovation and social responsibility is further exemplified by his membership in the Founders Pledge community, where he pledges to contribute to charitable causes.